Literature DB >> 16061043

Can we justify goal blood pressure of <140/90 mm Hg in most hypertensives?

Raymond R Townsend1.   

Abstract

Hypertension is a common disorder with well-recognized consequences on the heart, brain, and kidney as target organs. Guidelines espouse a treatment goal of blood pressure reduction to <140 mm Hg for the systolic pressure and <90 mm Hg for the diastolic pressure in most hypertensive patients. In this review, the basis for these recommendations, the practical achievement of these goals in various practice settings, and the risk versus the benefit of achieving such goals in most hypertensive patients are examined.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16061043     DOI: 10.1007/s11906-005-0022-3

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  61 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

2.  Characteristics of patients with uncontrolled hypertension in the United States.

Authors:  D J Hyman; V N Pavlik
Journal:  N Engl J Med       Date:  2001-08-16       Impact factor: 91.245

Review 3.  Prevalence, awareness, treatment and control of hypertension in North America, North Africa and Asia.

Authors:  P K Whelton; J He; P Muntner
Journal:  J Hum Hypertens       Date:  2004-08       Impact factor: 3.012

4.  Improvement of blood pressure control in a hypertension clinic: a 10-year follow-up study.

Authors:  Y Ohta; T Tsuchihashi; K Fujii; K Matsumura; Y Ohya; K Uezono; I Abe; M Iida
Journal:  J Hum Hypertens       Date:  2004-04       Impact factor: 3.012

5.  Ticrynafen's withdrawal from the market.

Authors:  W R Barclay
Journal:  JAMA       Date:  1980 Feb 22-29       Impact factor: 56.272

6.  Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial.

Authors:  Henry R Black; William J Elliott; Gregory Grandits; Patricia Grambsch; Tracy Lucente; William B White; James D Neaton; Richard H Grimm; Lennart Hansson; Yves Lacourciere; James Muller; Peter Sleight; Michael A Weber; Gordon Williams; Janet Wittes; Alberto Zanchetti; Robert J Anders
Journal:  JAMA       Date:  2003 Apr 23-30       Impact factor: 56.272

7.  Improving control of hypertension by an integrated approach -- results of the 'Manage it well!' programme.

Authors:  Laszlo A Szirmai; Csaba Arnold; Csaba Farsang
Journal:  J Hypertens       Date:  2005-01       Impact factor: 4.844

8.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

9.  Risk factors for uncontrolled hypertension in Italy.

Authors:  E Degli Esposti; M Di Martino; A Sturani; P Russo; C Dradi; S Falcinelli; S Buda
Journal:  J Hum Hypertens       Date:  2004-03       Impact factor: 3.012

10.  Why cardiovascular mortality is higher in treated hypertensives versus subjects of the same age, in the general population.

Authors:  Athanase Benetos; Frédérique Thomas; Kathryn E Bean; Louis Guize
Journal:  J Hypertens       Date:  2003-09       Impact factor: 4.844

View more
  1 in total

1.  How lifespan associated genes modulate aging changes: lessons from analysis of longitudinal data.

Authors:  Anatoliy I Yashin; Konstantin G Arbeev; Deqing Wu; Liubov S Arbeeva; Alexander Kulminski; Igor Akushevich; Irina Culminskaya; Eric Stallard; Svetlana V Ukraintseva
Journal:  Front Genet       Date:  2013-01-22       Impact factor: 4.599

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.